國立虎尾科技大學 |

Bioindustry ethics

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Bioindustry ethics/ David L. Finegold ... [et al.].
other author:	Finegold, David.
Published:	Amsterdam ;Elsevier Academic Press, : c2005.,
Description:	1 online resource (xi, 368 p.)
Notes:	Includes index.
Subject:	Biotechnology industries - Case studies. - Moral and ethical aspects -
Online resource:	http://www.sciencedirect.com/science/book/9780123693709
ISBN:	9780123693709

Bioindustry ethics
Bioindustry ethics[electronic resource] /David L. Finegold ... [et al.]. - Amsterdam ;Elsevier Academic Press,c2005. - 1 online resource (xi, 368 p.)

Includes index.

Includes bibliographical references and index.

Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes.

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

ISBN: 9780123693709

Source: 112794:112883Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

861760
Biotechnology industries
--Moral and ethical aspects--Case studies.Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: HD9999.B442 / B542 2005eb

Dewey Class. No.: 174/.96606

National Library of Medicine Call No.: 2006 G-784

Bioindustry ethics
LDR:02342cam a2200433Ia 4500 001 727330
005 20120813074406.0
006 m d
007 cr cn|||||||||
008 130125s2005 ne ob 001 0 eng d
019 $a 154363149 $a 441784716 $a 505077954 $a 648300386
020 $a 9780123693709
020 $a 0123693705
020 $a 9780080492513 (electronic bk.)
020 $a 0080492517 (electronic bk.)
020 $a 9786611005337
020 $a 6611005331
029 1 $a NZ1 $b 12434928
029 1 $a AU@ $b 000048129864
035 $a ocn162572851
037 $a 112794:112883 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCQ $d N $d YDXCP $d MERUC $d UBY $d E7B $d IDEBK $d OCLCQ
049 $a NTYA
050 4 $a HD9999.B442 $b B542 2005eb
060 4 $a 2006 G-784
060 4 $a WB 60 $b B615495 2005
072 7 $a BUS $x 008000 $2 bisacsh
082 0 4 $a 174/.96606 $2 22
245 0 0 $a Bioindustry ethics $h [electronic resource] / $c David L. Finegold ... [et al.].
260 $a Amsterdam ; $a Boston : $b Elsevier Academic Press, $c c2005.
300 $a 1 online resource (xi, 368 p.)
500 $a Includes index.
504 $a Includes bibliographical references and index.
505 0 $a Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes.
520 $a This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.
588 $a Description based on print version record.
650 0 $a Biotechnology industries $x Moral and ethical aspects $v Case studies. $3 861760
650 0 $a Pharmaceutical industry $x Moral and ethical aspects $v Case studies. $3 861761
650 0 $a Business ethics $x Moral and ethical aspects $v Case studies. $3 861762
650 1 2 $a Bioethics. $3 567376
650 2 2 $a Biotechnology $x ethics. $3 560479
650 2 2 $a Drug Industry $x ethics. $3 861763
650 2 2 $a Ethics, Business. $3 861764
650 6 $a Bio-industries $x Aspect moral $v Cas, �Etudes de. $3 861765
650 6 $a Industrie pharmaceutique $x Aspect moral $v Cas, �Etudes de. $3 861766
650 6 $a Morale des affaires $v Cas, �Etudes de. $3 861767
650 7 $a BUSINESS & ECONOMICS $x Business Ethics. $2 bisacsh $3 861768
655 4 $a Electronic books. $2 local $3 554714
700 1 $a Finegold, David. $3 861759
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780123693709
938 $a YBP Library Services $b YANK $n 2586479
938 $a ebrary $b EBRY $n ebr10186063
938 $a Ingram Digital eBook Collection $b IDEB $n 100533